Skip to content
Pretest - Tumor Board Tuesday - March 29, 2022 (ID: i788-26)
*
1.
Please list your first name, last name, and email:
(Required.)
First name:
Last name:
Email:
*
2.
What is your specialty?
(Required.)
*
3.
Analysis of which immunohistochemical markers is the best initial step in elucidating the primary site of carcinoma of unknown primary?
(Required.)
Chromogranin and synaptophysin
CK7 and CK20
GATA3 and SATB2
CD19 and CD20
*
4.
In lung cancer, somatic mutations in STK11 are associated with which of the following?
(Required.)
Increased progression-free survival
Increased overall survival
Decreased recurrence rate after chemoradiation
Increased resistance to immunotherapy